Skip to main content
OpenTrials
Completed

NCT Number: NCT06462885

Living Alone is Predictive of Non-home Discharge Following Elective Total Hip Arthroplasty: a Matched-pairs Cohort Analysis

The goal of this observational study is to assess the effect of living alone on total hip arthroplasty thirty-day outcomes. The main questions it aims to answer are:

Is living alone associated with discharge disposition (home versus non-home)? Is living alone associated with greater incidences of secondary adverse events?

Participants will be sampled from the 2021 American College of Surgeons National Surgical Quality Improvement Program

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Arthropathy of Hip Pathologic Processes Pathological Conditions, Signs and Symptoms Perioperative/Postoperative Complications Postoperative Complications

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Virginia

Charlottesville, Virginia, 22908, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective, non-emergent cases
  • Living alone
  • Living with others

Exclusion criteria

  • Fracture in surgical diagnosis
  • Hospital admission >1 day preoperatively
  • End-stage renal disease (preoperative)
  • Metastatic disease (preoperative)
  • Sepsis (preoperative)
  • Bleeding diathesis (preoperative)
  • American Society of Anesthesiologists Physical Status Classification 5

Treatment and study plan

home support, hiving alone

Behavioral

Home support: living alone

home support, living with others

Behavioral

Home support: living with others

Primary outcomes

  1. Discharge disposition

    Time frame: Thirty days

    Home versus non-home

Secondary outcomes

  1. Requiring home services

    Time frame: Thirty days

  2. Functional status at discharge

    Time frame: Thirty days

    Dependent versus independent

  3. Postoperative delirium

    Time frame: Thirty days

  4. Hospital length of stay

    Time frame: Thirty days

  5. Unplanned resource utilization

    Time frame: Thirty days

    Unplanned readmission and return to the operating room

  6. Wound complications

    Time frame: Thirty days

    Superficial surgical site infection (SSI), deep incisional SSI, organ space SSI, and wound dehiscence

  7. Systemic complications

    Time frame: Thirty days

    Cardiac arrest, myocardial infarction, stroke, reintubation, pneumonia, deep venous thrombosis, pulmonary embolism, bleeding, sepsis, septic shock, and acute kidney injury

  8. Bleeding events

    Time frame: Thirty days

    Requiring transfusion

  9. Mortality

    Time frame: Thirty days

Sponsors and collaborators

Lead sponsor

University of Virginia

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jun 17, 2024
Registry last updated
Jun 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.